Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

P0783 : Viral kinetics during interferon-free sofosbuvir containing treatment regimens in a real-life cohort of chronic hepatitis C patients with advanced liver disease

10.1016/s0168-8278(15)30986-7 ◽

2015 ◽

Vol 62 ◽

pp. S625 ◽

Cited By ~ 1

Author(s):

K. Kozbial ◽

C. Freissmuth ◽

R. Strassl ◽

R. Al-Zoairy ◽

A. Maieron ◽

...

Keyword(s):

Chronic Hepatitis ◽

Liver Disease ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real Life ◽

Advanced Liver Disease ◽

Viral Kinetics ◽

Treatment Regimens ◽

Treatment and outcome of genotype 4 chronic hepatitis C patients with pegylated interferon α-2b and ribavirin in a German real-life-setting

Zeitschrift für Gastroenterologie ◽

10.1055/s-0030-1269729 ◽

2011 ◽

Vol 49 (01) ◽

Author(s):

S Mauss ◽

E Zehnter ◽

MP Manns ◽

G Teuber ◽

T Dahhan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real Life ◽

Pegylated Interferon ◽

Interferon Α ◽

Genotype 4 ◽

Real Life Setting ◽

Baseline resistance-associated substitutions may impact DAA response among treatment failure chronic hepatitis C patients with pegylated interferon and ribavirin in real life

Antiviral Therapy ◽

10.3851/imp3369 ◽

2020 ◽

Author(s):

Shan Ren ◽

Feili Wei ◽

Yi Jin ◽

Junfeng Lu ◽

Zhimin He ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Treatment Failure ◽

Chronic Hepatitis C ◽

Real Life ◽

Pegylated Interferon ◽

THU-131-Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: A real-life study from the NAVIGATORE Lombardia and Veneto Networks

10.1016/s0618-8278(19)30406-2 ◽

2019 ◽

Vol 70 (1) ◽

pp. e217 ◽

Cited By ~ 1

Author(s):

Elisabetta Degasperi ◽

Angiola Spinetti ◽

Andrea Lombardi ◽

Simona Landonio ◽

Pier Giorgio Scotton ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real Life ◽

Direct Acting Antivirals ◽

Life Study ◽

Real Life Study ◽

Direct Acting ◽

Simeprevir and Sofosbuvir with or without Ribavirin in Genotype 1 Chronic Hepatitis C Patients: Efficacy and Safety in Real Life

10.1016/s0168-8278(16)01492-6 ◽

2016 ◽

Vol 64 (2) ◽

pp. S765-S766 ◽

Cited By ~ 1

Author(s):

H. Ramos ◽

J. Gómez ◽

P. Linares ◽

I. Martín ◽

C. Almohalla ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real Life ◽

Efficacy And Safety ◽

Genotype 1 ◽

P0793 : Estimating the number of chronic hepatitis C patients in need of treatment and projecting the disease burden during 2015–2030 under the interferon-free treatment regimens in Greece

10.1016/s0168-8278(15)30996-x ◽

2015 ◽

Vol 62 ◽

pp. S630

Author(s):

V. Sypsa ◽

I. Gountas ◽

G. Papatheodoridis ◽

K. Souliotis ◽

H. Razavi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Disease Burden ◽

Treatment Regimens ◽

Free Treatment ◽

Real Life Experience of Sofosbuvir Based Therapy for Chronic Hepatitis C Patients From North East India

Journal of Clinical and Experimental Hepatology ◽

10.1016/j.jceh.2016.06.017 ◽

2016 ◽

Vol 6 ◽

pp. S9

Author(s):

K.S. Prasanna ◽

Kamal Chetri ◽

Mukesh Agarwala ◽

Partha Roy ◽

Arvind Kelkar

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Life Experience ◽

Real Life ◽

North East India ◽

North East ◽

Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.13663 ◽

2017 ◽

Vol 32 (6) ◽

pp. 1230-1233 ◽

Cited By ~ 12

Author(s):

Henry Lik‐Yuen Chan ◽

Owen Tak‐Yin Tsang ◽

Yee‐Tak Hui ◽

James Fung ◽

Grace Chung‐Yan Lui ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hong Kong ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real Life ◽

Efficacy And Safety ◽

Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks

Digestive and Liver Disease ◽

10.1016/j.dld.2018.11.063 ◽

2019 ◽

Vol 51 ◽

pp. e15

Author(s):

E. Degasperi ◽

A. Spinetti ◽

A. Lombardi ◽

S. Landonio ◽

P. Scotton ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real Life ◽

Direct Acting Antivirals ◽

Life Study ◽

Real Life Study ◽

Direct Acting ◽

Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test

Journal of Medical Virology ◽

10.1002/jmv.25575 ◽

2019 ◽

Vol 91 (12) ◽

pp. 2158-2165

Author(s):

Eun Sun Jang ◽

Kyung‐Ah Kim ◽

Young Seok Kim ◽

In Hee Kim ◽

Byung Seok Lee ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Life Effectiveness ◽

Genotype 1B ◽